Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Amgen: Bioprocess intensification and integration key for next-generation manufacturing

Its new Singapore single-use plant is a fraction of the size of a conventional commercial facility but next-generation biomanufacturing at Amgen points to even smaller, more integrated sites.

GE looks to single-use modular BioParks to relieve capacity investment risk

Incorporating single-use and modular facilities into a vendor run bio-campus could reduce CAPEX spend dilemmas faced by drugmakers says GE Healthcare.

Aduro and Merck & Co to test Keytruda and CRS-207 in second cancer study

Merck & Co and Aduro Biotech have announced plans to test Keytruda combined with CRS-207 in patients suffering malignant pleural mesothelioma as a result of exposure to asbestos.

Therachon hires Catalent to make protein dwarfism drug for Ph I trial

Therachon AG has contracted Catalent Biologics to manufacture a candidate protein therapeutic for a rare form of dwarfism.

Thermo Fisher: $7.2bn Patheon sits in sweet spot for bioproduction business

Thermo Fisher says Patheon will become the most competitive biologics CDMO in the market through direct access to its bioprocessing technologies and capabalities.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...